Pet-yksikkö

Julkaisut 2002
Publications 2002

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto S et al. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
2 Aalto S et al. Neuroanatomical substrata of amusement and sadness: a PET activation study using film stimuli.
3 Asola M et al. Amino acid uptake in the skeletal muscle measured using (11C)methylaminoisobutyrate (MEAIB) and PET.
4 Bentzen L et al. Assessment of hypoxia in experimental mice tumours by (18F)fluoromisonidazole PET and pO2 electrode measurements.
5 Bettinardi V et al. Implementation and evaluation of a 3D one-step late reconstruction algorithm for 3D positron emission tomography brain studies using median root prior.
6 Eskola O et al. Synthesis of 3-((4-(4-(18F) fluorophenyl)piperazin-1-yl(methyl)-1H-pyrrolo(2,3-b)pyride.
7 Guan Z-Z et al. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.
8 Hagelberg N et al. mu-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
9 Hagelberg N et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity.
10 Hakala M et al. Severe somatization in women is associated with altered cerebral glucose metabolism.
11 Heinonen P et al. Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery.
12 Hujala K et al. Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.
13 Hällsten K et al. Rosiglitazone but not metaformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
14 Janatuinen T et al. Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies.
15 Jartti L et al. Increased carotid intima-media thickness in men born in east Finland: a twin study of the effects of birthplace and migration to Sweden on subclinical atherosclerosis.
16 Jartti L et al. Population-based twin study of the effects of migration from Finland to Sweden on endothelial function and intima-media thickness.
17 Joyal CC et al. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia.
18 Järvenpää T et al. Characteristics two telephone screens for cognitive impairment.
19 Järvisalo MJ et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children.
20 Järvisalo MJ et al. Carotid artery intima-media thickness in children with type 1 diabetes.
21 Järvisalo MJ et al. Brachial artery dilatation responses in healthy children and adolescents.
22 Kaasinen V et al. Age-related loss of extrastriatal dopamine D2-like receptors in women.
23 Kaasinen V et al. Personality traits and striatal 6-[18F] fluoro-L-dopa uptake in healthy elderly subjects.
24 Kaasinen V et al. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
25 Kaasinen V, Rinne JO. Functional imaging studies of dopamine system and cognition in normal aging in Parkinson's disease.
26 Kaisti K et al. Effects of surgical levels of propofol and sevoflurance anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography.
27 Kalliokoski K et al. Myocardial perfusion and perfusion reserve in endurance-trained men.
28 Kemppainen J et al. Myocardial and skeletal muscle glucose uptake during exercise in humans.
29 Kemppainen N. Brain dopamine transporter and receptors in Alzheimer's disease.
30 Kemppainen N et al. Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease.
31 Knuuti J, Någren K, eds. Turku PET Symposium. Abstracts of the IX Turku PET Symposium.
32 Knuuti J et al. The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction.
33 Kunnas TA et al. Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study.
34 Laakso A et al. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects.
35 Laaksonen R et al. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults.
36 Laine M et al. Different brain activation patterns during production of animals versus artefacts: a PET activation study on category-specific processing.
37 Laitio TT et al. Relation of heart rate dynamics to the occurence of myocardial ischemia after coronary artery bypass grafting.
38 Lee MS et al. COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson´s disease.
39 Lehtimäki T et al. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men.
40 Mattila KM et al. Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients.
41 Mattila KM et al. Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia.
42 Metsähonkala L et al. Focal and global cortical hypometabolism in patients with newly diagnosed infantile spasms.
43 Minn H et al. Anemia ja sädehoito.
44 Muhonen A, Muhonen A. Distraction osteogenesis of irradiated rabbit mandible with and without hyperbaric oxygen therapy.
45 Muhonen A et al. Osteodistraction of a previously irradiated mandible with or without adjunctive hyperbaric oxygenation: An experimental study in rabbits.
46 Muhonen A et al. The effects of irradiation and hyberbaric oxygen on bone formation during rabbit mandibular distraction.
47 Muhonen A et al. Osteoblastic activity of the rabbit temporomandibular joint during distraction osteogenesis assessed by [18F]fluoride positron emission tomography.
48 Mäenpää H et al. Glioomat.
49 Nakamoto Y et al. Reproducibility of common semi-quantitive parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-(18F)fluoro-D-glucose.
50 Niemi P et al. Cognitive functioning in severe somatization - a pilot study.
51 Persson J et al. Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity.
52 Pietilä M. 11C-hydroxyephedrine positron emission tomography in chronic heart failure.
53 Pietilä M et al. Exercise training in chronic heart failure: benficial effects on cardiac 11C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization.
54 Porela P et al. Jaksottainen hypokaleeminen tyreotoksinen paralyysi.
55 Päivä H et al. Plasma asymmetric diamethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
56 Reunanen K et al. Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study.
57 Rinne J. Other important dementias.
58 Rinne J et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
59 Rinne J et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.
60 Rinne J, Lee M. Neuroacanthocytosis.
61 Rinne J et al. Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
62 Roeda D et al. Synthesis of (11C)atipamezole, a potential PET ligand for the 2-adrenergic receptor in the brain.
63 Saito T et al. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics.
64 Salmi M et al. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
65 Salokangas R et al. Psykoosialttiuden arvioinnin opas.
66 Salokangas R et al. Negative symptoms and neuroleptics in catatonic schizophrenia.
67 Salokangas RKR et al. Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic deprssion and healthy controls. Results of the Schizophrenia and Affective Psychoses (SAP) project.
68 Sandell J et al. PET examination of (11C)5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.
69 Sandell J et al. Synthesis, radiolabeling and premilinary biological evluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.
70 Scheinin H. Ksenon - tulevaisuuden anesteetti?
71 Scheinin H. Miksi ja missä uusia lääkkeitä kehitetään?
72 Snäll N et al. A rare mitochondrial DNA haplotype observed in Koreans.
73 Sundell J et al. Obesity affects myocardial vasoreactivity and coronary flow response to insulin.
74 Sundell J et al. Increased coronary vascular resistance cannot be reduced by inhibiting sympathetic overactivity in hypertension.
75 Sundell J et al. The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes.
76 Sundell J et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow.
77 Sundell J. Insulin and myocardial blood flow. Studies using positron emission tomography.
78 Takala TO et al. 14(R,S)-(18F)Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
79 Toikka J et al. Decreased large artery distensibility in borderline hypertension is related to increased in vivo low-density lipoprotein oxidation.
80 Tolvanen T et al. 18F-fluoroerythronitroimidazole radiation dosimetry in cancer studies.
81 Utriainen M et al. Metabolic characterization of childhood brain tumors.
82 Viikari J et al. Nutritional influences on lipids and future atherosclerosis beginnig prenatally and during chidhood.
83 Virtanen K et al. 2-[18F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats.
84 Virtanen K et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese an obese humans.
85 Vähätalo J et al. Synthesis of 4-dihydroxyboryl-2-(18F) fluorophenylalanine wiht relatively high-specific activity.
Julkaisutietokanta 13.10.2004 Publications Data Base 13.10.2004